Advertisement

Different migratory and proliferative properties of smooth muscle cells of coronary and femoral artery

      Abstract

      In the human coronary arteries, the intima begins to thicken from early adolescence and shows progressive thickening with age. We compared the response to vascular injury of the coronary and femoral arteries using a canine model. Both incorporation of 5-bromo-2′-deoxyuridine (BrdU) and neointimal formation after balloon injury were significantly greater in the coronary artery than in the femoral artery. Also, the proliferative and migratory activities of coronary smooth muscle cells (SMCs) were significantly greater than those of femoral SMCs in vitro. The level of phosphorylated myosin light chain (phospho-MLC) was higher in coronary SMCs than in femoral SMCs. Y-27632, a specific inhibitor of Rho-kinase, significantly inhibited the PDGF-induced migration of both coronary and femoral SMCs. In contrast, the migration of coronary SMCs, but not femoral SMCs, was inhibited by ML-9, a specific inhibitor of myosin light chain kinase (MLCK). These findings suggest that the contribution of Rho-kinase and MLCK differs between the different arteries. They also suggest that a neointima develops more easily in the coronary artery than in the femoral artery because of the greater proliferative and migratory activity of coronary SMCs. Differential activation of MLC might partly explain the increased proliferation and migration of coronary SMCs.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ross R.
        The pathogenesis of atherosclerosis: perspective for the 1990s.
        Nature. 1993; 362: 801-809
        • Aikawa M.
        • Sivan P.N.
        • Kuro-o M.
        • Kimura K.
        • Nakahara K.
        • Takewaki S.
        • et al.
        Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis.
        Circ. Res. 1993; 73: 1000-1012
        • Ikari Y.
        • McManus B.M.
        • Kenyon J.
        • Schwartz S.M.
        Neonatal intima formation in the human coronary artery.
        Arterioscler Thromb. Vasc. Biol. 1999; 19: 2036-2040
        • Stary H.C.
        • Chandler A.B.
        • Glagov S.
        • Guyton J.R.
        • Insull Jr., W.
        • Rosenfeld M.E.
        • et al.
        A definition of initial, fatty streak, American Heart Association.
        Arterioscler Thromb. Vasc. Biol. 1994; 14: 840-856
        • Stary H.C.
        The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life.
        Eur. Heart J. 1990; 11: 3-19
        • Sims F.H.
        • Gavin J.B.
        • Vanderwee M.A.
        The intima of human coronary arteries.
        Am. Heart J. 1989; 118: 32-38
        • Baim D.S.
        • Donald E.C.
        • Samin K.S.
        • Kalon K.L.
        • Richard F.
        • Theodore L.S.
        • et al.
        Final results of the balloon vs. optimal atherectomy trial (BOAT).
        Circulation. 1998; 97: 322-331
        • Levine S.
        • Ewels C.J.
        • Rosing D R.
        • Kent K.M.
        Coronary angioplasty, clinical and angiographic follow-up.
        Am. J. Cardiol. 1985; 55: 673-676
        • Nobuyoshi M.
        • Kimura T.
        • Nosaka H.
        • Mioka S.
        • Ueno K.
        • Yokoi H.
        • et al.
        Restenosis after successful percutaneous transluminal coronary angioplasty, serial angiographic follow-up of 229 patients.
        J. Am. Coll. Cardiol. 1988; 12: 616-623
        • Gallino A.
        • Mahler F.
        • Probst P.
        • Nachbur B.
        Percutaneous transluminal angioplasty of the arteries of the lower limbs, a 5 year follow-up.
        Circulation. 1984; 70: 619-623
        • Becker G.J.
        • Barry T.K.
        • Michael D.D.
        Noncoronary angioplasty.
        Radiology. 1989; 170: 921-940
        • Vredenrijk M.K.
        • Gerardus J.
        • Willem F.M.
        • Paul J.B.
        Percutaneous transluminal angioplasty of the femoropopliteal artery, initial and long-term results.
        Radiology. 1985; 156: 325-328
        • Sakurada K.
        • Seto M.
        • Sasaki Y.
        Dynamics of myosin light chain phosphorylation at Ser19 and Thr18/Ser19 in smooth muscle cells in culture.
        Am. J. Physiol. 1998; 274: 1563-1572
        • Taylor D.A.
        • Stull J.T.
        Calcium dependence of myosin light chain phosphorylation in smooth muscle cells.
        J. Biol. Chem. 1988; 263: 14456-14462
        • Fukui R.
        • Shibata N.
        • Kohbayashi E.
        • Amakawa M.
        • Furutama D.
        • Hoshiga M.
        • et al.
        Inhibition of smooth muscle cell migration by the p21 cyclin-dependent kinase inhibitor (cip1).
        Atherosclerosis. 1997; 132: 53-59
        • Persechini A.
        • Kamm K.E.
        Different phosphorylated forms of myosin in contracting tracheal smooth muscle.
        J. Biol. Chem. 1986; 261: 6293-6299
        • Lin P.
        • Luby-Phelps K.
        • Stull J.T.
        Properties of filament-bound myosin light chain kinase.
        J. Biol. Chem. 1999; 274: 5987-5994
        • Adelstein R.S.
        • Conti M.A.
        Phosphorylation of platelet myosin increases actin-activated myosin ATPase activity.
        Nature. 1975; 256: 597-598
        • Ehrlich H.P.
        • Rockwell W.B.
        • Cornwell T.L.
        • Rajaratnam J.B.
        Demonstration of a direct role for myosin light chain kinase in fibroblast-populated collagen lattice contraction.
        J. Cell Physiol. 1991; 146: 1-7
        • Giuliano K.A.
        • Kolega J.
        • L R.
        • Taylor D.L.
        Myosin II phosphorylation and the dynamics of stress fibers in serum-deprived and stimulated fibroblasts.
        Mol. Biol. Cell. 1992; 3: 1037-1048
        • Holzapfel G.
        • Wehland J.
        • Weber K.
        Calcium control of actin-myosin based contraction in triton models of mouse 3T3 fibroblasts is mediated by the myosin light chain kinase(MLCK)-calmodulin complex.
        Exp. Cell Res. 1983; 148: 117-126
        • Kamm K.E.
        • Stull J.T.
        The function of myosin and myosin light chain kinase phosphorylation in smooth muscle.
        Annu. Rev. Pharmacol. Toxicol. 1985; 25: 593-620
        • Kerrick W.G.
        • Bourguignon L.Y.
        Regulation of receptor capping in mouse lymphoma T cells by Ca2+-activated myosin light chain kinase.
        Proc. Natl. Acad. Sci. U.S.A. 1984; 81: 165-169
        • Kolega J.
        • Taylor D.L.
        Gradients in the concentration and assembly of myosin II in living fibroblasts during locomotion and fiber transport.
        Mol. Biol. Cell. 1993; 4: 819-836
        • Wysolmerski R.B.
        • Lagunoff D.
        Involvement of myosin light-chain kinase in endothelial cell retraction.
        Proc. Natl. Acad. Sci. U.S.A. 1990; 87: 16-20
        • Sanders M.
        Molecular and cellular concepts in atherosclerosis.
        Pharmacol. Ther. 1994; 61: 109-153
        • Matsumura F.
        • Ono S.
        • Yamakita Y.
        • Totsukawa G.
        • Yamashiro S.
        Specific localization of serine 19 phosphorylated myosin II during cell locomotion and mitosis of cultured cells.
        J. Cell Biol. 1998; 140: 119-129
        • Mitchison T.J.
        • Cramer L.P.
        Actin-based cell motility and cell locomotion.
        Cell. 1996; 84: 371-379
        • Ai S.K.M.
        • Koike T.
        • Asai T.
        • Kanda S.
        • Maeda K.
        • Shibata T.
        • et al.
        Rho-Rho kinase is involved in smooth muscle cell migration through myosin light chain phosphorylation-dependent and independent pathways.
        Atherosclerosis. 2001; 155: 321-327
        • Totsukawa G.
        • Yamakita Y.
        • Yamashiro S.
        • Hartshorne D.J.
        • Sasaki Y.
        • Matsumura F.
        Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts.
        J. Cell Biol. 2000; 150: 797-806